| 560. |
EVALUATION OF EPIDERM FULL THICKNESS-300 (EFT-300) AS AN IN VITRO MODEL FOR SKIN IRRITATION: STUDIES ON ALIPHATIC HYDROCARBONS.
|
| 559. |
IN VITRO SKIN IRRITATION TESTING: IMPROVING THE SENSITIVITY OF THE EPIDERM SKIN IRRITATION TEST PROTOCOL.
|
| 558. |
THE MATTEK STORY — HOW THE THREE Rs PRINCIPLES LED TO 3-D TISSUE SUCCESS!
|
| 556. |
ASSESSMENT OF DERMAL TOXICITY OF NANOSILICA USING CULTURED KERATINOCYTES, A HUMAN SKIN EQUIVALENT MODEL AND AN IN VIVO MODEL.
|
| 546. |
OXIDATIVE STRESS AND INFLAMMATORY RESPONSE IN DERMAL TOXICITY OF SINGLE-WALLED CARBON NANOTUBES.
|
| 533. |
EYE AND SKIN IRRITATION IN 3-D HUMAN TISSUE CONSTRUCTS USING MTT AND ATP ENDPOINTS.
|
| 528. |
AN IN VITRO SKIN IRRITATION TEST (SIT) USING THE EPIDERM RECONSTRUCTED HUMAN EPIDERMAL (RHE) MODEL. (VIDEO Protocol)
|
| 515. |
FOLLOW-UP VALIDATION OF THE EPIDERM SKIN IRRITATION TEST (SIT): RESULTS OF A MULTI-CENTRE STUDY OF TWENTY REFERENCE TEST SUBSTANCES.
|
| 505. |
EVALUATION OF PRO-INFLAMMATORY BIOMARKERS OF IRRITATION IN HUMAN SKIN MODEL USING MULTIPLEXED IMMUNOASSAY.
|
| 491. |
DEVELOPMENT OF AN IN VITRO CORROSION/IRRITATION PREDICTION ASSAY USING THE EPIDERM™ SKIN MODEL.
|
| 489. |
ENSURING QUALITY OF IN VITRO ALTERNATIVE TEST METHODS: ISSUES AND ANSWERS.
|
| 486. |
EVALUATION OF EPIDERM FULL THICKNESS-300 (EFT-300) AS AN IN VITRO MODEL FOR SKIN IRRITATION.
|
| 478. |
INITIAL IN VITRO SCREENING APPROACH TO INVESTIGATE THE POTENTIAL HEALTH AND ENVIRONMENTAL HAZARDS OF ENVIROX™ – A NANOPARTICULATE CERIUM OXIDE DIESEL FUEL ADDITIVE.
|
| 464. |
COMPARISON OF HUMAN PATCH TEST AND 3D HUMAN SKIN MODEL RESULTS WITH CLASSIFICATION OF CHEMICALS BASED ON RABBIT DRAIZE TEST.
|
| 459. |
IN VITRO SKIN IRRITATION TEST: INCREASING THE SENSITIVITY OF THE EPIDERM SKIN IRRITATION PROTOCOL EVALUATED IN THE ECVAM SKIN IRRITATION VALIDATION STUDY.
|
| 444. |
AN IN VITRO SYSTEM FOR PREDICTING SKIN IRRITATION OF LIQUID ANTIPERSPIRANTS.
|
| 434. |
IN VITRO AND IN VIVO COMPARISON OF DERMAL IRRITANCY OF JET FUEL EXPOSURE USING EPIDERM (EPI-200) CULTURED HUMAN SKIN AND HAIRLESS RATS.
|
| 417. |
DESIGN PRINCIPLES OF CHEMICAL PENETRATION ENHANCERS FOR TRANSDERMAL DRUG DELIVERY.
|
| 401. |
EVALUATION OF EPIDERM™ AS A MODEL TO STUDY IRRITATION AFTER EXPOSURE TO VARIOUS ALIPHATIC HYDROCARBONS FOUND IN JET FUELS.
|
| 397. |
PROTEOMIC ANALYSIS OF THE RESPONSE OF EPIDERM™ CULTURES TO SODIUM LAURYL SULPHATE.
|
| 392. |
USE OF HUMAN SKIN EQUIVALENT CULTURES FOR COSMETIC BENEFIT SCREENING.
|
| 377. |
PROGRAM TO REDUCE ANIMAL TESTING FOR EPA REGISTRATIONS OF ANTIMICROBIAL PRODUCTS.
|
| 371. |
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING.
|
| 357. |
EVALUATION OF A TISSUE ENGINEERED HUMAN SKIN EPIDERM 3-D CULTURE AS A MODEL TO STUDY IRRITATION AFTER JET FUEL EXPOSURE.
|
| 355. |
LONG TERM REPRODUCIBILITY OF EPIDERM, AN EPIDERMAL MODEL FOR DERMAL TESTING AND RESEARCH.
|
| 354. |
HIGH-THROUGHPUT IN VITRO MODELS OF HUMAN EPIDERMIS AND OCULAR EPITHELIUM FOR PRECLINICAL SAFETY AND EFFICACY TESTING OF CONSUMER PRODUCTS AND PHARMACEUTICALS.
|
| 341. |
OPTIMISATION OF THE EPIDERM TEST PROTOCOL FOR THE UPCOMING ECVAM VALIDATION STUDY ON IN VITRO SKIN IRRITATION TESTS.
|
| 338. |
ASSESSMENT OF SKIN ABSORPTION AND METABOLISM OF ARACHIDONIC ACID & GLYCERYL ARACHIDONATE USING IN VITRO DIFFUSION CELL TECHNIQUES.
|
| 335. |
EFFECT OF A NEW BOTANICAL EXTRACT BASED ON THE RED ALGAE, PIKEA ROBUSTA, ON IN VIVO REDUCTION OF SURFACTANT-INDUCED SKIN IRRITATION.
|
| 317. |
FOLLOW-UP TO THE ECVAM PREVALIDATION STUDY ON IN VITRO TESTS FOR ACUTE SKIN IRRITATION.
|
| 299. |
ASSESSMENT OF HUMAN SKIN IRRITATION: VALIDATION OF IN VITRO MODELS.
|
| 288. |
USE OF PROTEOMIC TECHNOLOGIES FOR DISCOVERY OF NEW MARKERS OF SKIN IRRITATION IN VITRO.
|
| 283. |
RECONSTRUCTED SKIN KITS: REPRODUCIBILITY OF CUTANEOUS IRRITANCY TESTING.
|
| 276. |
THE USE OF STANDARDIZED HUMAN SKIN MODELS FOR CUTANEOUS PHARMACOTOXICOLOGY STUDIES.
|
| 275. |
RECONSTRUCTED HUMAN EPIDERMIS EQUIVALENTS.
|
| 270. |
PREDICTIVE ABILITY OF RECONSTRUCTED HUMAN EPIDERMIS EQUIVALENTS FOR THE ASSESSMENT OF SKIN IRRITATION OF COSMETICS.
|
| 269. |
EVALUATION OF RECONSTRUCTED HUMAN EPIDERMIS KITS FOR THE IN VITRO ASSESSMENT OF COSMETIC SAFETY.
|
| 268. |
USE OF DIFFERENTIAL DISPLAY-POLYMERASE CHAIN REACTION TO IDENTIFY GENES SELECTIVELY MODULATED BY CHEMICAL ALLERGENS IN RECONSTITUTED HUMAN EPIDERMIS.
|
| 265. |
PROTEOMIC AND MICROARRAY INVESTIGATION TO IDENTIFY POTENTIAL IN VITRO ENDPOINTS FOR SKIN IRRITATION.
|
| 258. |
IDENTIFICATION OF POTENTIAL IN VITRO ENDPOINTS FOR SKIN IRRITATION USING PROTEOMIC AND MICROARRAY ANALYSIS.
|
| 254. |
NEW PERSPECTIVES ON SKIN-COMPATIBLE DETERGENTS FOR SENSITIVE SKIN.
|
| 241. |
GENE EXPRESSION ANALYSIS OF EPIDERM™ FOLLOWING EXPOSURE TO SLS USING cDNA MICROARRAYS.
|
| 234. |
MICROARRAY ANALYSIS OF GENE EXPRESSION FOLLOWING EXPOSURE TO SKIN IRRITANTS.
|
| 228. |
AN IN VITRO METHOD FOR SCREENING ANTI-IRRITANTS ON UV AND CHEMICALLY TREATED, RECONSTITUTED, THREE DIMENSIONAL HUMAN SKIN.
|
| 224. |
EVALUATION OF THE USEFULNESS OF 3-D MODELS OF RECONSTITUTED HUMAN SKIN AND EPIDERMIS IN APPLICATIONS OF REGULATORY SKIN TOXICOLOGY: PREVALIDATION, VALIDATION, CATCH-UP VALIDATION, AND REGULATORY ACCEPTANCE.
|
| 223. |
HUMANE ENDPOINTS AND ACUTE TOXICITY TESTING.
|
| 222. |
IN VITRO AND HUMAN TESTING STRATEGIES FOR SKIN IRRITATION.
|
| 219. |
STRATEGIES FOR THE ASSESSMENT OF ACUTE SKIN IRRITATION POTENTIAL.
|
| 213. |
RECONSTRUCTED HUMAN SKIN EQUIVALENTS-THEIR VALUE FOR SCREENING OF SKIN IRRITATION.
|
| 209. |
A REPRODUCIBLE SKIN MODEL FOR DERMAL SAFETY AND EFFICACY TESTING.
|
| 205. |
A REPRODUCIBLE, STRUCTURALLY APPROPRIATE SKIN MODEL FOR DERMAL SAFETY AND EFFICACY TESTING.
|
| 199. |
CHARACTERIZATION AND COMPARISON OF RECONSTRUCTED SKIN MODELS: MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATION.
|
| 195. |
USE OF DIFFERENTIATED EPIDERMAL CULTURES FOR THE EXAMINATION OF INFANT-FECES-INDUCED SKIN IRRITATION.
|
| 187. |
IL-1α AND IL-1ra SECRETION FROM EPIDERMAL EQUIVALENTS AND THE PREDICTION OF THE IRRITATION POTENTIAL OF MILD SOAP AND SURFACTANT-BASED CONSUMER PRODUCTS.
|
| 186. |
THE INFLUENCE OF THE RESPONSE OF SKIN EQUIVALENT SYSTEMS TO TOPICALLY APPLIED CONSUMER PRODUCTS BY EPITHELIAL-MESENCHYMAL INTERACTIONS.
|
| 184. |
ASSESSMENT OF THE IRRITATION POTENTIAL OF TOPICAL SKIN ANTISEPTICS BY IN VIVO AND IN VITRO METHODS.
|
| 180. |
HUMAN IN VITRO AND IN VIVO CUTANEOUS RESPONSES TO SOAP SUSPENSIONS: ROLE OF SOLUTION BEHAVIOR IN PREDICTING POTENTIAL IRRITANT CONTACT DERMATITIS.
|
| 179. |
TESTING AND IMPROVEMENT OF RECONSTRUCTED SKIN KITS IN ORDER TO ELABORATE EUROPEAN STANDARDS: FIRST RESULTS.
|
| 174. |
COMPARISON OF IN VITRO AND IN VIVO HUMAN SKIN RESPONSES TO CONSUMER PRODUCTS AND INGREDIENTS WITH A RANGE OF IRRITANCY POTENTIAL.
|
| 170. |
DEVELOPMENT OF AN IN VITRO METHOD FOR SCREENING ANTI-IRRITANTS.
|
| 169A. |
ALTERNATIVE METHODS FOR SKIN IRRITATION TESTING: THE CURRENT STATUS.
|
| 166. |
FURTHER EVALUATION OF THE EPIDERM AND EPIOCULAR IN VITRO IRRITATION MODELS.
|
| 162. |
EVALUATION OF A NEW ALTERNATIVE TO PRIMARY DRAIZE SKIN IRRITATION TESTING USING THE EPIDERM SKIN MODEL.
|
| 157. |
IN VITRO SCREENING TECHNIQUES IN DERMATOLOGY.
|
| 154. |
BIOCONVERSION OF TOCOPHERYL ACETATE TO TOCOPHEROL IN HUMAN SKIN ORGAN CULTURE MODELS.
|
| 151. |
MATTEK'S TISSUE MODELS: NEW DEVELOPMENTS.
|
| 150. |
RECONSTITUTED 3-DIMENSIONAL HUMAN SKIN, A NEW IN VITRO MODEL FOR SKIN CARCINOGENESIS STUDY.
|
| 145. |
DEVELOPMENT OF AN IN VITRO MODEL FOR THE PREDICTION OF SKIN IRRITATION POTENTIAL.
|
| 143. |
PRESENCE OF HYDROCORTISONE DRAMATICALLY AFFECTS CYTOKINE PRODUCTION FOLLOWING UV IRRADIATION IN 3-DIMENSIONAL SKIN MODEL EPIDERM.
|
| 140. |
MODULATION OF CYTOKINE MESSAGE IN THE EPIDERM IN VITRO SKIN MODEL FOLLOWING TREATMENT WITH CONTACT ALLERGENS AND SKIN IRRITANTS.
|
| 137. |
SKIN IRRITATION POTENTIAL OF SURFACTANT MIXTURES: USING RELEVANT DOSES IN IN VITRO SYSTEMS.
|
| 136. |
A REPRODUCIBLE, STRUCTURALLY APPROPRIATE SKIN MODEL FOR DERMAL IRRITANCY AND EFFICACY TESTING.
|
| 134. |
COMPARISON OF IN VITRO AND IN VIVO HUMAN SKIN RESPONSES TO CONSUMER PRODUCTS AND INGREDIENTS WITH A RANGE OF IRRITANCY POTENTIAL.
|
| 133. |
CYTOKINE AND LIPID MEDIATOR RELEASE FROM IN VITRO SKIN MODELS FOLLOWING DETERGENT TREATMENT OR PHYSICAL WOUNDING.
|
| 127. |
THE USE OF MATTEK EPIDERMAL EQUIVALENTS FOR PREDICTION OF IRRITATION POTENTIAL.
|
| 125. |
DEVELOPMENT OF IN VITRO METHODS FOR EVALUATING THE EPIDERMAL AND DERMAL EFFECTS OF ALPHA HYDROXY AND AMIDES.
|
| 124. |
IN VITRO PERMEATION AND IRRITATION OF BENZOYL PEROXIDE - CONTAINING PRODUCTS.
|
| 123. |
PREDICTIVE TESTING: UNDERSTANDING THE ROLE OF IN VITRO AND IN VIVO TESTING.
|
| 121. |
CYTOKINE RESPONSE OF THE EPIDERM SKIN MODEL TO TOPICALLY APPLIED IRRITANTS AND TOXICANTS.
|
| 120. |
A COMPARISON OF THREE DIMENSIONAL HUMAN SKIN MODELS TO EVALUATE THE DERMAL IRRITATION OF SELECTED PETROLEUM PRODUCTS.
|
| 114. |
EVALUATION OF TWO IN VITRO HUMAN SKIN EQUIVALENTS (THE EPIDERM™ AND SKIN²™ MODEL ZK1300) FOR ASSESSING THE SKIN IRRITATION POTENTIAL OF PERSONAL CARE PRODUCTS AND CHEMICALS.
|
| 113. |
INTRA- AND INTERLABORATORY REPRODUCIBILITY (ET-50) OF EPIDERM, AN IN VITRO MODEL FOR DERMAL IRRITANCY TESTING.
|
| 112. |
LIPID AND ULTRASTRUCTURAL CHARACTERIZATION OF A NEW EPIDERMAL MODEL SHOWS GOOD CORRESPONDENCE TO NORMAL HUMAN EPIDERMIS.
|
| 108. |
COMPARISONS OF IN VITRO AND IN VIVO SKIN RESPONSES TO SURFACTANTS WITH A RANGE OF IRRITANCY POTENTIAL.
|
| 107. |
INTER-AND INTRALABORATORY REPRODUCIBILITY OF A THREE DIMENSIONAL HUMAN EPIDERMAL MODEL - EPIDERM.
|
| 106. |
LOT-TO-LOT VARIABILITY OF EPIDERM, AN EPIDERMAL MODEL FOR DERMAL IRRITANCY TESTING.
|
| 104. |
LIPID CHARACTERIZATION OF A NEW EPIDERMAL MODEL FOR SKIN IRRITANCY AND PENETRATION STUDIES.
|
| 103. |
NEW EPIDERMAL MODEL FOR DERMAL IRRITANCY TESTING.
|
| 102. |
INITIAL CHARACTERIZATION OF A NEW MODEL FOR DERMAL IRRITANCY TESTING.
|
| 101. |
NEW EPIDERMAL MODEL FOR DERMAL IRRITANCY TESTING.
|
